Identification of m6A methyltransferase-related WTAP and ZC3H13 predicts immune infiltrates in glioblastoma
Abstract Glioblastoma (GBM) is a prevalent and highly fatal primary malignant brain tumor. N6-methyladenosine (m6A) modification plays a critical role in the development of brain tumor. WTAP and ZC3H13 have been identified across various species. Immune contexture, which includes the tumor microenvi...
Saved in:
Main Authors: | Liyun Gao, Jiaxin Gao, Jiayin He, Wenyan Fan, Xiangxin Che, Xin Wang, Tao Wang, Chunhua Han |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-88671-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neurocognitive function and health-related quality of life among glioblastoma patients: A prospective study
by: Mohamed A Baba, et al.
Published: (2025-01-01) -
Near-infrared light triggered in situ release of CO for enhanced therapy of glioblastoma
by: Juan Ge, et al.
Published: (2023-02-01) -
Escherichia coli combination with PD-1 blockade synergistically enhances immunotherapy in glioblastoma multiforme by regulating the immune cells
by: Guochen Li, et al.
Published: (2025-02-01) -
A bird's eye view to the homeostatic, Alzheimer and Glioblastoma attractors
by: Joan Nieves, et al.
Published: (2025-02-01) -
Synergistic strategies for glioblastoma treatment: CRISPR-based multigene editing combined with immune checkpoint blockade
by: Xiaolin Liu, et al.
Published: (2025-02-01)